AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33528904 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin (25 mg/day) with simple meal announcement
Number of subjects: 30
Study 33528904 — intervention group
Group type: COMPARATOR
Intervention: Carbohydrate counting without empagliflozin (control)
Number of subjects: 30
Study 33528904 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin with carbohydrate counting
Number of subjects: 30
Study 33528904 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin
Number of subjects: 30
Study 32742512 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral counseling (8 sessions, 60-90 minutes each)
Number of subjects: 70
Study 32742512 — intervention group
Group type: COMPARATOR
Intervention: Control group (routine pregnancy care)
Number of subjects: 70
Study 32742512 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral counseling
Number of subjects: 70
Study 35961948 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab biosimilar
Number of subjects: 98
Study 35961948 — intervention group
Group type: COMPARATOR
Intervention: Bevacizumab
Number of subjects: 98
Study 34959773 — intervention group
Group type: EXPERIMENTAL
Intervention: EMG of the corrugator supercilii muscles
Number of subjects: 0
Study 34959773 — intervention group
Group type: EXPERIMENTAL
Intervention: EMG of the masseter and suprahyoid muscles
Number of subjects: 0
Study 34870133 — intervention group
Group type: EXPERIMENTAL
Intervention: SII-ChAdOx1 nCoV-19
Number of subjects: 1601
Study 32387298 — intervention group
Group type: EXPERIMENTAL
Intervention: General health, lifestyle and sexual behavior factors
Number of subjects: 14271
Study 32387298 — intervention group
Group type: EXPERIMENTAL
Intervention: Overweight
Number of subjects: 14271
Study 32387298 — intervention group
Group type: EXPERIMENTAL
Intervention: Obese
Number of subjects: 14271
Study 32387298 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived themselves as much too fat
Number of subjects: 14271
Study 32387298 — intervention group
Group type: EXPERIMENTAL
Intervention: Poor self-perceived health
Number of subjects: 14271
Study 32387298 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily smoking
Number of subjects: 14271
Study 32387298 — intervention group
Group type: EXPERIMENTAL
Intervention: Previous genital warts or other sexually transmitted infections
Number of subjects: 14271
Study 32387298 — intervention group
Group type: EXPERIMENTAL
Intervention: Young women with ≥10 lifetime sexual partners or ≥2 new recent partners
Number of subjects: 14271
Study 34493393 — intervention group
Group type: EXPERIMENTAL
Intervention: Health Star Rating
Number of subjects: 3584
Study 34493393 — intervention group
Group type: COMPARATOR
Intervention: High in labels
Number of subjects: 3584
Study 34493393 — intervention group
Group type: COMPARATOR
Intervention: Multiple traffic light
Number of subjects: 3584
Study 33372118 — intervention group
Group type: EXPERIMENTAL
Intervention: Recipe 4 Success
Number of subjects: 73
Study 33372118 — intervention group
Group type: COMPARATOR
Intervention: Usual practice Early Head Start
Number of subjects: 73
Study 32376293 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated Pcuff correction (combined with manual correction)
Number of subjects: 60
Study 32376293 — intervention group
Group type: COMPARATOR
Intervention: Manual Pcuff correction alone
Number of subjects: 60
Study 32376293 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study 36483239 — intervention group
Group type: EXPERIMENTAL
Intervention: Electro-acupuncture (EA) combined with physical exercise for 2 weeks with a 26-week follow-up.
Number of subjects: 110
Study 36483239 — intervention group
Group type: COMPARATOR
Intervention: Control group with no EA intervention.
Number of subjects: 110
Study 32272776 — intervention group
Group type: EXPERIMENTAL
Intervention: Online hemodiafiltration (HDF)
Number of subjects: 80
Study 32272776 — intervention group
Group type: COMPARATOR
Intervention: Low-flux hemodialysis (HD)
Number of subjects: 80
Study 32272776 — intervention group
Group type: EXPERIMENTAL
Intervention: Residual kidney function (RKF)
Number of subjects: 80
Study 32272776 — intervention group
Group type: EXPERIMENTAL
Intervention: PBUT plasma concentrations
Number of subjects: 80
Study 33516240 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi training for 12 weeks, 36 sessions of 60 minutes each
Number of subjects: 64
Study 33516240 — intervention group
Group type: COMPARATOR
Intervention: Waiting list group maintaining routine lifestyle
Number of subjects: 64
Study 36111386 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised therapeutic exercise intervention (tailored multicomponent exercise program for 8 weeks, two supervised sessions per week with resistance and aerobic training, plus a third day of monitored light intensity continuous training)
Number of subjects: 39
Study 36111386 — intervention group
Group type: COMPARATOR
Intervention: WHO rehabilitation guidelines (control group)
Number of subjects: 39
Study 34823467 — intervention group
Group type: EXPERIMENTAL
Intervention: Eptinezumab 100 mg, 300 mg, 1000 mg
Number of subjects: 0
Study 34823467 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32713463 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical release by a posterior approach without triceps detachment, followed by a rehabilitation protocol similar to the conservative group.
Number of subjects: 30
Study 32713463 — intervention group
Group type: COMPARATOR
Intervention: Rehabilitation protocol associated with the use of orthoses (static progressive for extension and dynamic for flexion) and continuous passive motion.
Number of subjects: 30
Study 35490438 — intervention group
Group type: EXPERIMENTAL
Intervention: Two nights of restricted four-hour sleep
Number of subjects: 46
Study 35490438 — intervention group
Group type: COMPARATOR
Intervention: Two nights of habitual eight-hour sleep
Number of subjects: 46
Study 34981490 — intervention group
Group type: EXPERIMENTAL
Intervention: Lentil group (500 mg of lentil powder daily for 3 months)
Number of subjects: 60
Study 34981490 — intervention group
Group type: COMPARATOR
Intervention: Placebo group (placebo daily for 3 months)
Number of subjects: 60
Study 35190087 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided percutaneous drainage
Number of subjects: 128
Study 35190087 — intervention group
Group type: COMPARATOR
Intervention: Surgical drainage
Number of subjects: 128
Study 33680304 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal HUDs (n = 24) for patient care/self‐directed learning
Number of subjects: 47
Study 33680304 — intervention group
Group type: COMPARATOR
Intervention: No HUDs (n = 23)
Number of subjects: 47
Study 33680304 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal HUDs (n = 24)
Number of subjects: 47
Study 32503494 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimetazidine (35 mg twice a day)
Number of subjects: 124
Study 32503494 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 124
Study 35729250 — intervention group
Group type: EXPERIMENTAL
Intervention: L-menthol (n=26)
Number of subjects: 52
Study 35729250 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=26)
Number of subjects: 52
Study 35729250 — intervention group
Group type: EXPERIMENTAL
Intervention: L-menthol
Number of subjects: 52
Study 35729250 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 34250817 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide (glucagon-like peptide-1 receptor agonist)
Number of subjects: 50
Study 32073934 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin-to-skin contact (SSC)
Number of subjects: 128
Study 32073934 — intervention group
Group type: COMPARATOR
Intervention: Control group (no SSC)
Number of subjects: 128
Study 36036907 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumbar epidural steroid injections (LESIs)
Number of subjects: 3259
Study 36036907 — intervention group
Group type: COMPARATOR
Intervention: Control treatment in the RCT of LESI
Number of subjects: 3259
Study 35866910 — intervention group
Group type: EXPERIMENTAL
Intervention: Baricitinib in combination with topical corticosteroids
Number of subjects: 0
Study 33200220 — intervention group
Group type: EXPERIMENTAL
Intervention: Baricitinib 4 mg monotherapy
Number of subjects: 148
Study 33200220 — intervention group
Group type: EXPERIMENTAL
Intervention: Baricitinib 4 mg (+MTX)
Number of subjects: 148
Study 33200220 — intervention group
Group type: COMPARATOR
Intervention: Placebo (+MTX) switched to Baricitinib 4 mg (+MTX)
Number of subjects: 148
Study 34330756 — intervention group
Group type: COMPARATOR
Intervention: Anterior‐posterior 12.5% depth
Number of subjects: 32
Study 34330756 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterior‐posterior 25% depth
Number of subjects: 32
Study 34330756 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterior‐posterior 33% depth
Number of subjects: 32
Study 34330756 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterior‐posterior 40% depth
Number of subjects: 32
Study 32811629 — intervention group
Group type: EXPERIMENTAL
Intervention: Take-home naloxone (THN) administration with positive communication
Number of subjects: 47
Study 32811629 — intervention group
Group type: EXPERIMENTAL
Intervention: Take-home naloxone (THN) administration with negative communication
Number of subjects: 47
Study 32811629 — intervention group
Group type: EXPERIMENTAL
Intervention: Withdrawal symptoms
Number of subjects: 47
Study 36141823 — intervention group
Group type: EXPERIMENTAL
Intervention: Freediving training + Pulmonary Rehabilitation (FD + PR)
Number of subjects: 69
Study 36141823 — intervention group
Group type: COMPARATOR
Intervention: Pulmonary Rehabilitation (PR)
Number of subjects: 69
Study 33812910 — intervention group
Group type: COMPARATOR
Intervention: 3% Hypertonic Saline (HTS)
Number of subjects: 0
Study 33812910 — intervention group
Group type: EXPERIMENTAL
Intervention: Desmopressin (D-HTS) in addition to 3% Hypertonic Saline
Number of subjects: 0
Study 35420844 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-directed mindfulness training
Number of subjects: 127
Study 35420844 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 127
Study 33906847 — intervention group
Group type: EXPERIMENTAL
Intervention: CHW
Number of subjects: 593
Study 33906847 — intervention group
Group type: EXPERIMENTAL
Intervention: CHW+CCT
Number of subjects: 593
Study 33906847 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 593
Study 32822650 — intervention group
Group type: EXPERIMENTAL
Intervention: Indwelling catheterization
Number of subjects: 252
Study 32822650 — intervention group
Group type: COMPARATOR
Intervention: Intermittent catheterization (every 2 hours)
Number of subjects: 252
Study 34654643 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl (FENTA)
Number of subjects: 6
Study 34654643 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl plus glycopyrrolate (FENTAglyco)
Number of subjects: 6
Study 34654643 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl (FENTA) with prevention of bradycardia
Number of subjects: 6
Study 34431970 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-6 levels ≥2.0 ng/L
Number of subjects: 14611
Study 33739848 — intervention group
Group type: COMPARATOR
Intervention: RT (Radiotherapy)
Number of subjects: 2014
Study 33739848 — intervention group
Group type: EXPERIMENTAL
Intervention: RT plus T (Radiotherapy plus Trastuzumab)
Number of subjects: 2014
Study 32846762 — intervention group
Group type: EXPERIMENTAL
Intervention: CBT-Music intervention program
Number of subjects: 53
Study 32846762 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 53
Study 36308628 — intervention group
Group type: EXPERIMENTAL
Intervention: Effective Communication within the Organization (ECO) program
Number of subjects: 191
Study 36308628 — intervention group
Group type: COMPARATOR
Intervention: Psychoeducative lectures (PE) about pain and stress
Number of subjects: 191
Study 33053258 — intervention group
Group type: EXPERIMENTAL
Intervention: Action-Based Cognitive Remediation (ABCR)
Number of subjects: 61
Study 33053258 — intervention group
Group type: COMPARATOR
Intervention: Control treatment
Number of subjects: 61
Study 32492705 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT) - 10×1-minute at 90%HRmax, 1-minute active recovery (n=16)
Number of subjects: 31
Study 32492705 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-Intensity Continuous Training (MICT) - 45 minutes at 70%HRmax (n=15)
Number of subjects: 31
Study 33867420 — intervention group
Group type: EXPERIMENTAL
Intervention: Probucol
Number of subjects: 1025
Study 33867420 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 1025
Study 32749173 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral EGCG 100 mg twice daily for 10 days
Number of subjects: 97
Study 32749173 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 97
Study 36127760 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent case management intervention (4-month duration, including two home or clinic visits and two telephone interviews)
Number of subjects: 76
Study 36127760 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent case management intervention
Number of subjects: 76
Study 36127760 — intervention group
Group type: COMPARATOR
Intervention: Routine care and two social phone calls (control group)
Number of subjects: 76
Study 33629114 — intervention group
Group type: EXPERIMENTAL
Intervention: Aromatase inhibitors (AIs) adherence
Number of subjects: 702
Study 33629114 — intervention group
Group type: EXPERIMENTAL
Intervention: Younger patients (younger than age 65 years)
Number of subjects: 702
Study 33629114 — intervention group
Group type: EXPERIMENTAL
Intervention: Composite risk model based on baseline PRO scales
Number of subjects: 702
Study 33629114 — intervention group
Group type: EXPERIMENTAL
Intervention: Highest-risk patients
Number of subjects: 702
Study 33262578 — intervention group
Group type: EXPERIMENTAL
Intervention: Evogliptin 5 mg alone (EVO)
Number of subjects: 34
Study 33262578 — intervention group
Group type: EXPERIMENTAL
Intervention: Glimepiride 4 mg alone (GLI)
Number of subjects: 34
Study 33262578 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of evogliptin and glimepiride (EVO+GLI)
Number of subjects: 34
Study 35622848 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled nitric oxide (iNO) as an adjunct to standard of care with medical oxygen
Number of subjects: 0
Study 35622848 — intervention group
Group type: COMPARATOR
Intervention: Standard of care with medical oxygen
Number of subjects: 0
Study 34459744 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based video 'Mon Coeur, Mon BASIC' and a short interview with the pharmacist
Number of subjects: 60
Study 34459744 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 60
Study 34459744 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based video 'Mon Coeur, Mon BASIC'
Number of subjects: 60
Study 32106619 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 0
Study 32106619 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 0
Study 36425572 — intervention group
Group type: EXPERIMENTAL
Intervention: PMA-ZEO
Number of subjects: 104
Study 36425572 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104
Study 34024187 — intervention group
Group type: EXPERIMENTAL
Intervention: Iodine excretion level in urine among school-aged children
Number of subjects: 1455
Study 34024187 — intervention group
Group type: EXPERIMENTAL
Intervention: Iodine excretion level in urine among pregnant women
Number of subjects: 1455
Study 36153475 — intervention group
Group type: EXPERIMENTAL
Intervention: Itacitinib (a selective JAK1 inhibitor) combined with ASTX727 (a fixed dose oral combination of decitabine and cedazuridine)
Number of subjects: 0
Study 36153475 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 34698724 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized CAD/CAM healing abutments
Number of subjects: 20
Study 34698724 — intervention group
Group type: COMPARATOR
Intervention: Conventional healing abutments
Number of subjects: 20
Study 32244424 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-Taped Kinesio Taping (DTKT)
Number of subjects: 44
Study 32244424 — intervention group
Group type: COMPARATOR
Intervention: Normal-Tape Kinesio Taping (NTKT)
Number of subjects: 44
Study 32244424 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 33556804 — intervention group
Group type: EXPERIMENTAL
Intervention: Oseltamivir
Number of subjects: 0
Study 33556804 — intervention group
Group type: EXPERIMENTAL
Intervention: Zanamivir
Number of subjects: 0
Study 33556804 — intervention group
Group type: EXPERIMENTAL
Intervention: Laninamivir
Number of subjects: 0
Study 33556804 — intervention group
Group type: EXPERIMENTAL
Intervention: Peramivir
Number of subjects: 0
Study 33920935 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training (EG1)
Number of subjects: 113
Study 33920935 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic training (EG2)
Number of subjects: 113
Study 33920935 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 113
Study 34627832 — intervention group
Group type: EXPERIMENTAL
Intervention: Serratus anterior plane block (SAPB) with 0.4 mL.kg-1 0.5% ropivacaine
Number of subjects: 40
Study 34627832 — intervention group
Group type: COMPARATOR
Intervention: Thoracic paravertebral block (TPVB)
Number of subjects: 40
Study 32359776 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg intravenous metoclopramide
Number of subjects: 150
Study 32359776 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg intravenous dexketoprofen trometamol
Number of subjects: 150
Study 32359776 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg dexketoprofen trometamol + 10 mg metoclopramide
Number of subjects: 150
Study 34796658 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief CBT-based telephone counseling
Number of subjects: 2628
Study 32131911 — intervention group
Group type: EXPERIMENTAL
Intervention: CORDIAL program (11 individual weekly sessions of CBT, cognitive rehabilitation, and reminiscence therapy)
Number of subjects: 198
Study 32131911 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual (Control group)
Number of subjects: 198
Study 35691664 — intervention group
Group type: EXPERIMENTAL
Intervention: Tinzaparin
Number of subjects: 301
Study 34636493 — intervention group
Group type: EXPERIMENTAL
Intervention: Q-switched Nd:YAG laser with daily 3% tranexamic acid gel
Number of subjects: 60
Study 34636493 — intervention group
Group type: EXPERIMENTAL
Intervention: Microneedling with daily 3% tranexamic acid gel
Number of subjects: 60
Study 34636493 — intervention group
Group type: COMPARATOR
Intervention: Both interventions
Number of subjects: 60
Study 34706816 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative MRI
Number of subjects: 396
Study 34706816 — intervention group
Group type: EXPERIMENTAL
Intervention: Younger patients with invasive lobular tumors
Number of subjects: 396
Study 34706816 — intervention group
Group type: COMPARATOR
Intervention: Female surgeons
Number of subjects: 396
Study 34706816 — intervention group
Group type: COMPARATOR
Intervention: Surgeons in community practice
Number of subjects: 396
Study 34706816 — intervention group
Group type: EXPERIMENTAL
Intervention: Time period of the study
Number of subjects: 396
Study 33122573 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (DEX)
Number of subjects: 102
Study 33122573 — intervention group
Group type: COMPARATOR
Intervention: Midazolam (MDZ)
Number of subjects: 102
Study 32727548 — intervention group
Group type: EXPERIMENTAL
Intervention: Simparica Trio® (combination of sarolaner, moxidectin, and pyrantel)
Number of subjects: 622
Study 32727548 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 622
Study 32727548 — intervention group
Group type: EXPERIMENTAL
Intervention: Survey study
Number of subjects: 622
Study 34971551 — intervention group
Group type: EXPERIMENTAL
Intervention: KUR-113 (0.4 mg/mL)
Number of subjects: 200
Study 34971551 — intervention group
Group type: COMPARATOR
Intervention: Standard of Care (SoC)
Number of subjects: 200
Study 34971551 — intervention group
Group type: EXPERIMENTAL
Intervention: KUR-113 (0.133 mg/mL)
Number of subjects: 200
Study 34971551 — intervention group
Group type: EXPERIMENTAL
Intervention: KUR-113 (1.0 mg/mL)
Number of subjects: 200
Study 32168551 — intervention group
Group type: EXPERIMENTAL
Intervention: Palonosetron 0.75 mg (day 1) combined with dexamethasone and fosaprepitant
Number of subjects: 326
Study 32168551 — intervention group
Group type: COMPARATOR
Intervention: Granisetron 1 mg (day 1) combined with dexamethasone and fosaprepitant
Number of subjects: 326
Study 36386031 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated case investigation and contact tracing (CICT)
Number of subjects: 106522
Study 36386031 — intervention group
Group type: COMPARATOR
Intervention: Manual case investigation and contact tracing (CICT)
Number of subjects: 106522
Study 33640345 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote Patient Monitoring (RPM)
Number of subjects: 1450
Study 33640345 — intervention group
Group type: COMPARATOR
Intervention: Conventional care
Number of subjects: 1450
Study 33640345 — intervention group
Group type: EXPERIMENTAL
Intervention: Alert driven
Number of subjects: 1450
Study 35104166 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin pump infusion sets (various types)
Number of subjects: 263
Study 35104166 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin pump infusion sets (90° Teflon)
Number of subjects: 263
Study 35104166 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin pump infusion sets (angled Teflon)
Number of subjects: 263
Study 35104166 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin pump infusion sets (steel)
Number of subjects: 263
Study 35104166 — intervention group
Group type: EXPERIMENTAL
Intervention: Age groups (youth vs adults)
Number of subjects: 263
Study 33219706 — intervention group
Group type: EXPERIMENTAL
Intervention: Constraint-induced movement therapy (CIMT)
Number of subjects: 21
Study 33219706 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 21
Study 35428722 — intervention group
Group type: EXPERIMENTAL
Intervention: SEC 300 mg
Number of subjects: 258
Study 35428722 — intervention group
Group type: EXPERIMENTAL
Intervention: SEC 150 mg
Number of subjects: 258
Study 35428722 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 258